Lv3
290 积分 2021-07-26 加入
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
1天前
待确认
Structure-Guided Optimization of 2-Aminoquinazoline Hematopoietic Progenitor Kinase 1 Inhibitors for Improved Oral Bioavailability and Synergistic Antitumor Immunity
1天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
29天前
已完结
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
2个月前
已完结
Can autoimmune diseases be cured? Scientists see hope at last
5个月前
已完结
Autoimmune diseases: targets, biology, and drug discovery
5个月前
已完结
Autoimmune diseases: targets, biology, and drug discovery
6个月前
已完结
Understanding autoimmune disease: new targets for drug discovery
6个月前
已完结
皖公网安备34019202002308
